Per Richard Torbjörn Hallberg
Fortune : 4 M $ au 30/06/2026
Fortune : 4 M $ au 30/06/2026
Per Richard Torbjörn Hallberg is currently Director at Takeda Oy since 2016, Director at Dova Pharmaceuticals, Inc. since 2019, Director at Swedish Orphan Biovitrum, Inc., Director at Swedish Orphan Biovitrum (Belgium) SARL since 2021, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB since 2018.
Former roles include Senior Associate at Advokatfirman Lindahl KB from 1997 to 2001, Corporate Counsel at Ferring Pharmaceuticals, Inc. from 2001 to 2004, Corporate Counsel at Nycomed AB from 2004 to 2010, and Vice President & General Counsel-Emerging Markets at Takeda AB from 2015 to 2017.
Education includes graduate studies at the University of Lund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 78 949 ( 0,02 % ) | 4 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Conseiller Juridique Général | 01/01/2018 |
| DOVA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/11/2019 |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/05/2016 |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Directeur/Membre du Conseil | - |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Directeur/Membre du Conseil | 01/06/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Takeda AB | Directeur/Membre du Conseil | 01/01/2017 |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Conseiller Juridique Général | 01/01/2010 |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Conseiller Juridique Général | 01/01/2004 |
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2001 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Takeda AB | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national